(Q41190059)

28 September 2017

title

Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues (English)

1 reference

28 September 2017

Ekaterina G Kochkina

1

1 reference

28 September 2017

Svetlana A Plesneva

2

1 reference

28 September 2017

Dmitrii S Vasilev

3

1 reference

28 September 2017

Igor A Zhuravin

4

1 reference

28 September 2017

Anthony J Turner

5

1 reference

28 September 2017

Natalia N Nalivaeva

6

1 reference

28 September 2017

language of work or name

1 reference

20 March 2015

1 reference

28 September 2017

1 reference

28 September 2017

volume

16

1 reference

28 September 2017

issue

4

1 reference

28 September 2017

page(s)

473-484

1 reference

https://scigraph.springernature.com/pub.10.1007/s10522-015-9569-9

28 September 2017

exact match

0 references

cites work

Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Can Alzheimer disease be a form of type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Nuclear signalling by membrane protein intracellular domains: the AICD enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Potential roles of insulin and IGF-1 in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Systemic catabolism of Alzheimer's Abeta40 and Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

The role of proteolysis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

The Aβ-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Transcriptional regulation of insulin-degrading enzyme modulates mitochondrial amyloid β (Aβ) peptide catabolism and functionality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

The mechanisms of alloxan- and streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Impaired amyloid β-degrading enzymes in brain of streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Age-Dependent Changes in the Sensitivity of the Rat to a Diabetogenic Agent (Streptozotocin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Effect of sodium valproate administration on brain neprilysin expression and memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Reduced insulin clearance and lower insulin-degrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Neuroscience. Insulin insults may spur Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Insulin-degrading enzyme (IDE): a novel heat shock-like protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-015-9569-9

10.1007/S10522-015-9569-9

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference